Harmony Biosciences Hldg Inc (HRMY) returns
Harmony Biosciences Hldg returns over 5 years
$1,000 invested in Harmony Biosciences Hldg five years ago was worth $934.65 at the close on October 30, 2026, with dividends reinvested: an average return of -1.3% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -1.3% | — | $987.26 | -0.9% |
| 3 months | +8.1% | — | $1,081 | +2.1% |
| Year to date | +3.6% | — | $1,036 | +11.7% |
| 1 year | +34.1% | — | $1,341 | +12.4% |
| 3 years | +96.7% | +25.3% | $1,967 | +88.5% |
| 5 years | -6.5% | -1.3% | $934.65 | +76.0% |
Harmony Biosciences Hldg return by calendar year
| Year | HRMY | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +3.6% | +11.7% | -8.1% |
| 2025 | +8.7% | +17.7% | -9.0% |
| 2024 | +6.5% | +24.9% | -18.4% |
| 2023 | -41.4% | +26.2% | -67.6% |
| 2022 | +29.2% | -18.2% | +47.4% |
| 2021 | +18.0% | +28.7% | -10.8% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: HRMY financials · HRMY valuation
No forecast, no recommendation. This page describes Harmony Biosciences Hldg Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.